Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Feb 2021 01:22 PM
RNS
Holding(s) in Company
01 Feb 2021 09:05 AM
RNS
Second Price Monitoring Extn
01 Feb 2021 09:00 AM
RNS
Price Monitoring Extension
01 Feb 2021 07:00 AM
RNS
Total Voting Rights
29 Jan 2021 09:05 AM
RNS
Second Price Monitoring Extn
29 Jan 2021 09:00 AM
RNS
Price Monitoring Extension
28 Jan 2021 09:05 AM
RNS
Second Price Monitoring Extn
28 Jan 2021 09:00 AM
RNS
Price Monitoring Extension
28 Jan 2021 07:00 AM
RNS
Distribution agreement with Beckman Coulter
25 Jan 2021 11:35 AM
RNS
Holding(s) in Company
25 Jan 2021 11:05 AM
RNS
Second Price Monitoring Extn
25 Jan 2021 11:00 AM
RNS
Price Monitoring Extension
18 Jan 2021 12:29 PM
RNS
Holding(s) in Company
18 Jan 2021 07:00 AM
RNS
Notice of Results
30 Dec 2020 12:50 PM
RNS
Result of AGM
23 Dec 2020 11:39 AM
RNS
Holding(s) in Company
21 Dec 2020 02:48 PM
RNS
Response to new COVID strain
17 Dec 2020 09:12 AM
RNS
Holding(s) in Company
16 Dec 2020 09:05 AM
RNS
Second Price Monitoring Extn
16 Dec 2020 09:00 AM
RNS
Price Monitoring Extension
16 Dec 2020 07:00 AM
RNS
Notification of intent to distribute in the USA
11 Dec 2020 07:00 AM
RNS
Conversion of Remaining Loan Notes
07 Dec 2020 07:00 AM
RNS
Additional Listing
03 Dec 2020 07:00 AM
RNS
AIHL hospital study completion
30 Nov 2020 07:00 AM
RNS
Block listing Interim Review
26 Nov 2020 04:41 PM
RNS
Second Price Monitoring Extn
26 Nov 2020 04:35 PM
RNS
Price Monitoring Extension
20 Nov 2020 07:00 AM
RNS
High clinical accuracy in India study
17 Nov 2020 07:00 AM
RNS
Final Results
10 Nov 2020 11:05 AM
RNS
Second Price Monitoring Extn
10 Nov 2020 11:00 AM
RNS
Price Monitoring Extension
02 Nov 2020 04:40 PM
RNS
Second Price Monitoring Extn
02 Nov 2020 04:35 PM
RNS
Price Monitoring Extension
29 Oct 2020 07:00 AM
RNS
Notice of Results
28 Oct 2020 04:41 PM
RNS
Second Price Monitoring Extn
28 Oct 2020 04:36 PM
RNS
Price Monitoring Extension
22 Oct 2020 07:00 AM
RNS
Point-of-Care solution to detect SARS-CoV-2 virus
19 Oct 2020 12:44 PM
RNS
Holding(s) in Company
12 Oct 2020 11:18 AM
RNS
Holding(s) in Company
09 Oct 2020 07:00 AM
RNS
Holding(s) in Company
06 Oct 2020 07:00 AM
RNS
Holding(s) in Company
01 Oct 2020 06:09 PM
RNS
Holding(s) in Company
30 Sep 2020 07:00 AM
RNS
South African approval
28 Sep 2020 07:00 AM
RNS
Partial Conversion of Loan Notes
25 Sep 2020 07:00 AM
RNS
Verification with Beckman Coulter Life Sciences
21 Sep 2020 09:40 AM
RNS
Holding(s) in Company
18 Sep 2020 02:06 PM
RNS
Second Price Monitoring Extn
18 Sep 2020 02:01 PM
RNS
Price Monitoring Extension
17 Sep 2020 09:27 AM
RNS
Holding(s) in Company
16 Sep 2020 03:15 PM
RNS
Holding(s) in Company

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings